Helptext

Movies



Company Information

Company NameOncology Venture Sweden AB
Company Idea

"Oncology Venture AB was formed in 2012 by Danish and US oncology specialists and business people dedicated to unlock the potential of oncology products that has shown efficacy but not enough to beat the gold standard - to improve the efficacy of the drugs, increase the response rate in cancer patients, reduce timelines and through this improve success rates in Oncology Drug Development."

Phone+45 21 70 10 49CEOPeter Buhl Jensen
E-mailinfo(snabel-a)oncologyventure(punkt)comChairm. of the BoardDuncan Moore
Homepagehttp://www.oncologyventure.com 

Instrument Information

Full NameOncology VentureShort NameOV
No of shares10,074,794Par Value0.14 SEK
TypeShareISIN codeSE0007157409

Price Information

+/-(0.60)
%-1.38
Latest43.00
High44.20
Low42.50
Volume4,095
Turnover (SEK)178,483
Market Cap (MSEK)433

Orders

VolumeBidAskVolume
11941.7043.20500
30841.0043.30400
8740.5043.50850
66737.3043.70600
70037.2043.802,000
  43.90700
  44.001,110
  44.101,162
  44.201,493
  44.40600
  44.5097
  44.601,000
  44.70600
  44.80100
  44.9079
  45.4055
  46.901,723
  47.001,000
  50.00500
  50.25400

Deals

TimeBuyerSellerPriceVolume
2:01 PMNONAVA43.005
1:41 PMDDBAVA43.00500
1:39 PMNONNON42.50400
1:38 PMAVAJYB42.6044
1:27 PMNONJYB42.90100
1:07 PMNONAVA43.00165
11:56 AMNONAVA43.40150
11:51 AMNONDDB43.70200
11:09 AMAVAAVA43.804
10:58 AMAVAMLI43.60100

Scheduled Reports

DateReport
2017-05-08Årsstämma
2017-05-19Delårsrapport ett
2017-08-25Halvårsrapport
2017-11-23Delårsrapport tre
2018-02-09Bokslutskommuniké för 2017




  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se